ORPHAN DRUGS VERSUS ULTRA-ORPHAN DRUGS: PRICE COMPARISON IN ENGLAND

被引：0
|
作者：
Chachoua, L. [1 ]
Hanna, E. [2 ]
Zhou, J. [3 ]
Dussart, C. [4 ]
Toumi, M. [3 ]
机构：
[1] Market Access Soc, Paris, France
[2] Creat Ceut, Paris, France
[3] Aix Marseille Univ, Marseille, France
[4] Lyon 1 Univ, Lyon, France
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.822
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY6
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [1] ORPHAN VERSUS ULTRA-ORPHAN DRUGS PRICES IN ENGLAND
    Achour, L.
    Hanna, E.
    Borrisov, B.
    Toumi, M.
    VALUE IN HEALTH, 2018, 21 : S446 - S446
  • [2] Ultra-orphan drugs: can we afford the price
    Menon, Devidas
    Stafinski, Tania
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (08): : 611 - 612
  • [3] TITLE: ACCESS TO ORPHAN AND ULTRA-ORPHAN DRUGS IN CHINA
    Gambari, J.
    Yang, M.
    Chowdhury, C. A.
    Duttagupta, S.
    VALUE IN HEALTH, 2016, 19 (07) : A826 - A826
  • [4] MARKET ACCESS AND PRICING ANALYSIS OF ULTRA-ORPHAN DRUGS
    Malacan, J.
    Gabriel, S.
    Dinet, J.
    Forget, S.
    Borget, I
    VALUE IN HEALTH, 2016, 19 (03) : A257 - A257
  • [5] International differences in patient access to ultra-orphan drugs
    Kanters, Tim A.
    Redekop, W. Ken
    Hakkaart, Leona
    HEALTH POLICY AND TECHNOLOGY, 2018, 7 (01) : 57 - 64
  • [6] HOW DOES THE SCOTTISH MEDICINES CONSORTIUM ASSESS THE VALUE OF ORPHAN AND ULTRA-ORPHAN DRUGS?
    Rothwell, B.
    VALUE IN HEALTH, 2017, 20 (09) : A568 - A568
  • [7] Involving Patients in Reducing Decision Uncertainties Around Orphan and Ultra-Orphan Drugs: A Rare Opportunity?
    Menon, Devidas
    Stafinski, Tania
    Dunn, Andrea
    Short, Hilary
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2015, 8 (01): : 29 - 39
  • [8] Involving Patients in Reducing Decision Uncertainties Around Orphan and Ultra-Orphan Drugs: A Rare Opportunity?
    Devidas Menon
    Tania Stafinski
    Andrea Dunn
    Hilary Short
    The Patient - Patient-Centered Outcomes Research, 2015, 8 : 29 - 39
  • [9] The quality of economic evaluations of ultra-orphan drugs in Europe - a systematic review
    Schuller, Y.
    Hollak, C. E. M.
    Biegstraaten, M.
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [10] The quality of economic evaluations of ultra-orphan drugs in Europe – a systematic review
    Y. Schuller
    C. E. M. Hollak
    M. Biegstraaten
    Orphanet Journal of Rare Diseases, 10
12345